Lipoxin
Lipoxin[edit]
Lipoxins are a class of specialized pro-resolving mediators (SPMs) derived from arachidonic acid. They play a crucial role in the resolution of inflammation and the maintenance of tissue homeostasis. Lipoxins are synthesized through a series of enzymatic reactions involving lipoxygenases and are known for their potent anti-inflammatory and pro-resolving properties.
Discovery[edit]
Lipoxins were first discovered in the early 1980s by Serhan and colleagues during their studies on the metabolism of arachidonic acid. They found that the interaction between leukocytes and platelets led to the production of lipoxins, which were later identified as potent lipid mediators involved in the resolution of inflammation.
Synthesis[edit]
The synthesis of lipoxins begins with the release of arachidonic acid from cell membrane phospholipids. This free arachidonic acid is then converted into 15-hydroperoxyeicosatetraenoic acid (15-HPETE) by the action of 15-lipoxygenase (15-LOX). 15-HPETE is further converted into lipoxin A4 (LXA4) through a series of enzymatic reactions involving the action of various enzymes, including 5-lipoxygenase (5-LOX) and 12-lipoxygenase (12-LOX).
Functions[edit]
Lipoxins exert their biological effects by binding to specific receptors on target cells. They have been shown to regulate various cellular processes, including inflammation, immune response, and tissue repair. Lipoxins promote the resolution of inflammation by inhibiting the recruitment of neutrophils, promoting the clearance of apoptotic cells, and stimulating the production of anti-inflammatory cytokines.
Clinical Significance[edit]
Due to their potent anti-inflammatory and pro-resolving properties, lipoxins have attracted significant attention in the field of medicine. Studies have shown that lipoxins can be used as therapeutic agents for the treatment of various inflammatory diseases, including asthma, arthritis, and inflammatory bowel disease. Additionally, lipoxins have been found to play a role in the resolution of chronic wounds and tissue regeneration.
References[edit]
1. Serhan CN, et al. Lipoxins: a novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc Natl Acad Sci U S A. 1984;81(17):5335-5339. doi:10.1073/pnas.81.17.5335
2. Bannenberg GL, et al. Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration. Br J Pharmacol. 2004;143(1):43-52. doi:10.1038/sj.bjp.0705915
See Also[edit]
- Arachidonic Acid
- Inflammation
- Specialized Pro-resolving Mediators
- Lipoxygenase
- Neutrophils
- Cytokines
- Asthma
- Arthritis
- Inflammatory Bowel Disease
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian